BriaCell Therapeutics Corp. (BCTX)

Price$3.49Cached quote
BCTXNasdaq
Loading local price history

Financial charts

Total cash / debt

CashTotal debt

Financial statements

7 annual periodsNewest to oldest
2025202420232022202120202019
Revenue—$0$0$0———
Research & development$21.3M$27.2M$15.3M$8.0M$2.0M$2.4M—
Operating expenses$27.2M$33.3M$23.3M$15.3M$7.0M$3.9M—
Operating income−$27.2M−$33.3M−$23.3M−$15.3M−$7.0M−$3.9M—
EBITDA−$27.1M−$33.2M−$23.3M−$15.3M−$7.0M−$3.9M—
Net income−$26.3M−$4.8M−$20.3M−$26.8M−$13.8M−$4.0M−$4.7M
Basic EPSper basic share-$62.19-$43.68-$195.00-$259.50-$459.00——
Diluted EPSper diluted share-$62.19-$43.68-$195.00-$259.50———

Owners

Reported shareholders

Reference date Jun 30, 2026

Reported holdings Number of shares

View holders
Top 18 reported holders of BCTX
HolderShares held
Cable Car Capital, LP
216.82K
SABBY MANAGEMENT, LLC
80.72K
IRIDIAN ASSET MANAGEMENT LLC/CT
65K
UBS Group AG
43.64K
HRT FINANCIAL LP
34.9K
JANE STREET GROUP, LLC
26.52K
LuminArx Capital Management LP
15K
NATIONAL BANK OF CANADA /FI/
1.8K
MORGAN STANLEY
1.03K
Federation des caisses Desjardins du Quebec
450
ROYAL BANK OF CANADA
289
Allworth Financial LP
100
SSA SWISS ADVISORS AG
37
Caitong International Asset Management Co., Ltd
34
TD Waterhouse Canada Inc.
19
GROUP ONE TRADING LLC
16
HHM Wealth Advisors, LLC
6
WELLS FARGO & COMPANY/MN
1

Bars compare reported share counts. A matching total for this share class and reporting period is unavailable, so percentages are not shown.

Source: SEC Form 13F ↗Updated Sep 29, 2026 · Quarterly data

Insider buys & sells

Jul 1, 2024–Jun 30, 2026
Buys0$0.00 disclosed value
Sells (SEC code S)0$0.00 disclosed value
0 recent transactions
No insider transactions transactions were reported in the stored SEC coverage.

Community posts

It’s quiet here.

No posts about BCTX yet. Start the conversation.

Write the first post